ITI Pharma and Healthcare Fund · Regular · Growth
NAV
₹16.5770
as of 16 Jun 2026
Expense Ratio
2.35%
AUM
₹217 Cr
Lumpsum returns (CAGR)
- 1Y
- +1.18%
- 3Y
- +18.26%
- 5Y
- —
- Since Inception
- +11.61%
SIP returns (XIRR)
- 1Y
- +8.75%
- 3Y
- +10.61%
- 5Y
- —
- Since Inception
- +13.90%
Beat the benchmark — ₹500/month SIP
Same SIP in this fund vs the benchmark index
This fund
₹37,704
Benchmark
₹34,393
+₹3,311 extra wealth vs the benchmark index
Backtest this SIP yourselfSIP since inception — what ₹500/month became
Real NAV backtest from day one
₹27,500
Invested
₹37,704
Value today
14.1%
XIRR (p.a.)
₹500/month SIP from fund inception · Current value as of today
Try SIP Calculator with this fund's history₹1,000 lumpsum at launch — value today
Invested on the fund's first NAV date
₹1,000
Invested
₹1,658
Value today
11.7%
CAGR (p.a.)
One-time investment at fund inception · Growth purely from NAV appreciation
Try Lumpsum Calculator₹6L corpus via 12-month STP from a liquid fund at inception
₹50K/month transferred from HDFC Liquid → this fund at launch
₹6,00,000
Invested
₹10,75,342
Value today
+8.1%
vs lumpsum
STP beat direct lumpsum by 8.1% — reduced timing risk paid off
Model your own STP with real NAVRisk Metrics
Trailing 1 year, annualised-0.43
Sharpe Ratio
-0.06
Alpha
0.36
Beta
-0.40
Sortino
15.61%
Std Dev
-17.64%
Max Drawdown
Performance Comparison
Thinking about ITI Pharma and Healthcare Fund · Regular · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Fund Details
Available transactions
Investment Objective
ITI Pharma and Healthcare Fund · Regular · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
ITI Pharma and Healthcare Fund · Regular · Growth is a Sectoral / Thematic mutual fund offered by ITI Mutual Fund. The fund has been operational for over 4 years. It manages assets worth ₹217 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against NIFTY 500 TRI. The current expense ratio is 2.35%.
Who Should Invest?
- •Investors with a high risk appetite seeking long-term wealth creation
- •Investors with an investment horizon of 5 years or more
- •SIP investors who can benefit from rupee cost averaging during market fluctuations